Patterns of nuclear fluorescence and DNA-binding activity.
作者信息
Luciano A, Rothfield N F
出版信息
Ann Rheum Dis. 1973 Jul;32(4):337-41. doi: 10.1136/ard.32.4.337.
Abstract
摘要
相似文献
1
Patterns of nuclear fluorescence and DNA-binding activity.
Ann Rheum Dis. 1973 Jul;32(4):337-41. doi: 10.1136/ard.32.4.337.
2
[Antinuclear autoantibodies in systemic diseases].
Vestn Dermatol Venerol. 1980 Nov(11):17-22.
3
Two new antinuclear antibodies: their relationship to the homogeneous immunofluorescent pattern.
Arthritis Rheum. 1968 Feb;11(1):37-43. doi: 10.1002/art.1780110105.
4
Immunofluorescent method for the detection of antigammaglobulin antibodies.
Arthritis Rheum. 1973 Jan-Feb;16(1):59-65. doi: 10.1002/art.1780160109.
5
Role of nuclear antigens and antinuclear antibodies in inflammation.
Biochem Pharmacol. 1968 Mar:Suppl:77-86. doi: 10.1016/0006-2952(68)90295-5.
6
The clinical significance of titered antinuclear antibodies.
Arthritis Rheum. 1967 Dec;10(6):544-52. doi: 10.1002/art.1780100607.
7
Rheumatic disease sera reactive with capillaries in the mouse kidney.
Arthritis Rheum. 1972 Jan-Feb;15(1):23-8. doi: 10.1002/art.1780150104.
8
Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
Ann Rheum Dis. 1974 Sep;33(5):465-72. doi: 10.1136/ard.33.5.465.
9
10
Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality.
J Hyg Epidemiol Microbiol Immunol. 1970;14(3):303-12.
引用本文的文献
1
Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet.
J Clin Invest. 1981 Feb;67(2):476-85. doi: 10.1172/JCI110056.
2
Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus.
J Clin Invest. 1976 Jan;57(1):212-21. doi: 10.1172/JCI108262.
3
Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis.
Ann Rheum Dis. 1975 Oct;34(5):444-50. doi: 10.1136/ard.34.5.444.
4
A double antibody solid phase assay for DNA autoantibodies for clinical use.
Clin Exp Immunol. 1976 Aug;25(2):191-8.
5
Relation of titred peripheral pattern ANA to anti-DNA and disease activity in systemic lupus erythematosus.
Ann Rheum Dis. 1977 Feb;36(1):44-9. doi: 10.1136/ard.36.1.44.
本文引用的文献
1
SPECIFIC NUCLEAR REACTION PATTERN OF ANTIBODY TO DNA IN LUPUS ERYTHEMATOSUS SERA.
J Lab Clin Med. 1963 Oct;62:625-31.
2
Interaction of nuclei and globulin from lupus erythematosis serum demonstrated with fluorescent antibody.
J Immunol. 1958 Apr;80(4):324-9.
3
Complement fixation with cell nuclei and DNA in lupus erythematosus.
Proc Soc Exp Biol Med. 1957 Dec;96(3):575-9. doi: 10.3181/00379727-96-23545.
4
A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus.
Proc Soc Exp Biol Med. 1957 Dec;96(3):572-4. doi: 10.3181/00379727-96-23544.
5
Measurement of serum DNA-binding activity in systemic lupus erythematosus.
N Engl J Med. 1969 Sep 25;281(13):701-5. doi: 10.1056/NEJM196909252811304.
6
Studies on DNA antibodies using DNA labelled with actinomycin-D (3H) or dimethyl (3H) sulphate.
Clin Exp Immunol. 1969 May;4(5):527-36.
7
Serum anti-gamma-globulin and antinuclear factors in the aged.
JAMA. 1967 Feb 13;199(7):455-8.
8
Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide.
Ann Rheum Dis. 1971 May;30(3):259-64. doi: 10.1136/ard.30.3.259.
9
Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid.
Science. 1968 Aug 23;161(3843):806-7. doi: 10.1126/science.161.3843.806.
10
Serum antinuclear antibodies in rheumatoid arthritis.
Conn Med. 1970 Mar;34(3):171-6.
Zotero 插件